PCRX
Pacira BioSciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$26.35
−0.94%Margins
Gross margin
79.2%
EBITDA margin
15.4%
EBIT margin
2.5%
Net margin
2.0%
FCF margin
24.1%
2.2%
Return on equity
1.2%
Return on assets
1.7%
Return on invested capital
0.61x
Asset turnover
$187.7M
Cash from operations
$6.30
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026